Inhibition of YB-1 alone or in combination with TMZ may improve GBM treatment
Glioblastoma is a rare, but devastating brain tumor. Recent studies showed that GBM is correlated with Y-box binding protein-1 (YB-1) overexpression both in pediatric and adult patients. YB-1 is a member of the cold shock domain protein superfamily. It performs a wide variety of cellular functions,...
Main Author: | Gao, Yuanyuan |
---|---|
Language: | English |
Published: |
University of British Columbia
2009
|
Online Access: | http://hdl.handle.net/2429/14697 |
Similar Items
-
Inhibition of YB-1 alone or in combination with TMZ may improve GBM treatment
by: Gao, Yuanyuan
Published: (2009) -
Inhibition of YB-1 alone or in combination with TMZ may improve GBM treatment
by: Gao, Yuanyuan
Published: (2009) -
OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth
by: Rheal A. Towner, et al.
Published: (2019-02-01) -
Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation
by: Luca Napoleoni, et al.
Published: (2019-01-01) -
Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma
by: Qinghua Wu, et al.
Published: (2018-12-01)